- Investing Ideas
- Global Pharmaceuticals & Biotech High Return On Equity, Low Debt
Global Pharmaceuticals & Biotech High Return On Equity, Low Debt
Results
44
Stocks with a return on equity of over 30% and a debt to equity ratio below 1.
44 companies
Roche Holding
Market Cap: CHF 283.6b
Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.
ROP
CHF 355.10
7D
-3.3%
1Y
38.7%
Orion Oyj
Market Cap: €10.9b
Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.
ORNBV
€77.40
7D
-5.0%
1Y
14.2%
Exelixis
Market Cap: US$12.5b
An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.
EXEL
US$51.24
7D
-5.2%
1Y
33.8%
RemeGen
Market Cap: HK$70.7b
A biopharmaceutical company, discovers, develops, produces, and commercializes biological drugs for the treatment of autoimmune, oncology, and ophthalmic diseases in Mainland China and the United States.
9995
HK$80.70
7D
-6.4%
1Y
4.7%
Shanghai Allist Pharmaceuticals
Market Cap: CN¥54.2b
A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China in internationally.
688578
CN¥120.40
7D
2.9%
1Y
31.6%
Sunshine Guojian Pharmaceutical (Shanghai)
Market Cap: CN¥43.4b
A biopharmaceutical company, engages in the research and development, production, and sale of antibody drugs.
688336
CN¥48.40
7D
3.1%
1Y
35.1%
Abbott India
Market Cap: ₹575.4b
Operates as a pharmaceutical company in India.
500488
₹27,076.90
7D
-2.5%
1Y
-18.5%
SK Biopharmaceuticals
Market Cap: ₩6.8t
A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.
A326030
₩87,300.00
7D
2.2%
1Y
-13.2%
GlaxoSmithKline Pharmaceuticals
Market Cap: ₹455.5b
Manufactures, distributes, and trades in pharmaceuticals in India and internationally.
500660
₹2,689.10
7D
3.7%
1Y
-2.9%
Suzhou Zelgen Biopharmaceuticals
Market Cap: CN¥31.9b
Engages in the research, development, manufacture, sale, and distribution of medicines in the People's Republic of China.
688266
CN¥120.40
7D
-1.1%
1Y
6.4%
Shenyang Xingqi PharmaceuticalLtd
Market Cap: CN¥14.8b
Engages in the research, development, production, and sale of ophthalmic drugs in the People’s Republic of China.
300573
CN¥41.40
7D
-2.8%
1Y
-4.9%
ADMA Biologics
Market Cap: US$2.1b
A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.
ADMA
US$9.47
7D
-4.3%
1Y
-44.3%
MeiraGTx Holdings
Market Cap: US$1.3b
A clinical-stage genetic medicines company, focusing on developing treatments for patients with serious diseases.
MGTX
US$13.52
7D
3.4%
1Y
65.5%
BioGaia
Market Cap: SEK 11.4b
A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.
BIOG B
SEK 113.00
7D
1.3%
1Y
19.6%
Oscotec
Market Cap: ₩1.4t
Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.
A039200
₩37,400.00
7D
7.0%
1Y
8.4%
Basilea Pharmaceutica
Market Cap: CHF 658.2m
A Swiss commercial-stage biotech company focused on developing and commercializing treatments for severe bacterial and fungal infections.
BSLN
CHF 53.10
7D
2.5%
1Y
2.1%
Sanofi India
Market Cap: ₹74.8b
Manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally.
500674
₹3,246.40
7D
-3.0%
1Y
-36.2%
CorMedix
Market Cap: US$634.5m
A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.
CRMD
US$7.54
7D
1.3%
1Y
-41.7%
Qyuns Therapeutics
Market Cap: HK$3.9b
A clinical-stage biotech company, engages in the research and development of biologic therapies for autoimmune and allergic diseases in China.
2509
HK$17.64
7D
1.7%
1Y
-21.5%
Rafa Laboratories
Market Cap: ₪1.4b
A pharmaceutical company, manufactures, markets, and distributes prescription (Rx) and over-the-counter (OTC) medicines in Israel.
RAFA
₪14.50
7D
-12.1%
1Y
n/a
Q32 Bio
Market Cap: US$451.0m
A clinical-stage biotechnology company, develops novel biologics to restore healthy immune balance in patients with alopecia areata and other autoimmune and inflammatory diseases driven by pathological immune dysfunction.
QTTB
US$15.15
7D
-2.9%
1Y
669.0%
Elite Pharmaceuticals
Market Cap: US$386.1m
A specialty pharmaceutical company, engages in the development, manufacture, and sale of oral, controlled-release products, and generic pharmaceuticals.
ELTP
US$0.31
7D
-14.1%
1Y
-42.9%
Compugen
Market Cap: US$228.3m
A clinical-stage therapeutic discovery and development company, engages in the research, development, and commercialization of therapeutics and product candidates in Israel, the United States, and Europe.
CGEN
US$2.41
7D
0%
1Y
68.5%
Hester Biosciences
Market Cap: ₹20.5b
Manufactures and trades in veterinary vaccines and health products in India and internationally.
524669
₹2,413.65
7D
-0.2%
1Y
27.0%
Shukra Pharmaceuticals
Market Cap: ₹18.2b
Manufactures and markets pharmaceutical products in India and internationally.
524632
₹41.43
7D
6.1%
1Y
130.8%
Saniona
Market Cap: SEK 1.8b
A clinical-stage biopharmaceutical company, focuses on discovering, developing, and delivering innovative treatments for neurological and psychiatric disorders in Ireland, the United States, Germany, Denmark, and the United Kingdom.
SANION
SEK 12.89
7D
-4.5%
1Y
55.9%
Kahira Pharmaceuticals & Chemical Industries
Market Cap: ج.م8.0b
Manufactures, packages, distributes, and trades in pharmaceutical products in Egypt and internationally.
CPCI
ج.م534.19
7D
10.2%
1Y
146.2%
Quality Chemical Industries
Market Cap: USh584.3b
Engages in the manufactures and sells pharmaceutical drugs in Uganda.
QCIL
USh160.00
7D
0%
1Y
45.5%
BLS Pharmaceuticals
Market Cap: AU$216.2m
Manufactures and distributes therapeutic goods, and health and wellness products in Australia, the United States, the United Kingdom, Czech Republic, and Japan.
BLS
AU$0.94
7D
3.3%
1Y
77.4%
Hoechst Pakistan
Market Cap: PK₨38.4b
Together with its subsidiary, manufactures, sells, and trades in pharmaceutical and related products in Pakistan, Afghanistan, and internationally.
HPL
PK₨3,985.00
7D
0.2%
1Y
13.6%
Vaxart
Market Cap: US$136.0m
A clinical-stage biotechnology company, discovers and develops oral recombinant protein vaccines based on its vector-adjuvant-antigen standardized technology proprietary oral vaccine platform.
VXRT
US$0.54
7D
-1.3%
1Y
48.5%
Alexandria For Pharmaceuticals & Chemical Industries
Market Cap: ج.م6.5b
Operates as a pharmaceutical company in Egypt.
AXPH
ج.م1,305.43
7D
2.9%
1Y
93.2%
NATURLAND Holding Vagyonkezelo es Befektetesi Nyilvanosan Mukodo Reszvenytarsasag
Market Cap: Ft39.0b
Manufactures and sells pharmaceutical products in Hungary.
NATURLAND
Ft2,820.00
7D
-0.7%
1Y
8.5%
Merck
Market Cap: Rp1.7t
Engages in the manufacture and sale of pharmaceutical products in Indonesia and internationally.
MERK
Rp3,890.00
7D
-1.8%
1Y
39.4%
Rallybio
Market Cap: US$90.1m
A clinical-stage biotechnology company, engages in the development and commercialization of life-transforming therapies for patients suffering from severe and rare diseases.
RLYB
US$16.99
7D
5.1%
1Y
251.6%
JW Shinyak
Market Cap: ₩117.3b
Engages in the research, development, production, and sale of medicines and medical supplies in South Korea.
A067290
₩2,100.00
7D
-3.7%
1Y
39.6%